PARTI . Overview We are a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases such as pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). We operate through our wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC, formerly known as RareGen. We currently generate revenue through the sale of YUTREPIA (trepro...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001104659-26-023804 | EDGAR | 101K words |
| 2025-03-19 | 2024-12-31 | 0001558370-25-003237 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0001558370-24-003051 | EDGAR | — |
| 2023-03-20 | 2022-12-31 | 0001558370-23-004191 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0001558370-22-003850 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001437749-21-007174 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001104659-25-105215 | EDGAR | 67K words |
| 2025-08-12 | 2025-06-30 | 0001558370-25-011139 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001558370-25-006848 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001558370-24-015433 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001558370-24-011206 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001558370-24-007991 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001558370-23-017842 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014376 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001558370-23-008392 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001558370-22-016873 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013274 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001558370-22-008524 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-05 | 0001104659-26-023794 | EDGAR | 3K words |
| 2026-01-09 | 0001104659-26-002306 | EDGAR | — |
| 2025-11-03 | 0001104659-25-105199 | EDGAR | — |
| 2025-10-30 | 0001104659-25-104000 | EDGAR | — |
| 2025-08-12 | 0001104659-25-076412 | EDGAR | — |
| 2025-07-01 | 0001104659-25-064738 | EDGAR | — |
| 2025-06-24 | 0001104659-25-061835 | EDGAR | — |
| 2025-06-18 | 0001104659-25-060654 | EDGAR | — |
| 2025-06-18 | 0001104659-25-060649 | EDGAR | — |
| 2025-06-02 | 0001104659-25-055180 | EDGAR | — |
142 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001819576 |
| Ticker | LQDA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.liquidia.com |
| Listed | 2018-07-26 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report